NYSE:RAD - Rite Aid Stock Price, Forecast & News

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Rite Aid's stock reverse split on the morning of Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

Rite Aid Co. (NYSE:RAD) issued its quarterly earnings results on Thursday, December, 19th. The company reported $0.54 EPS for the quarter, topping the Zacks' consensus estimate of $0.09 by $0.45. The company had revenue of $5.46 billion for the quarter, compared to analyst estimates of $5.42 billion. Rite Aid had a negative net margin of 1.86% and a positive return on equity of 1.40%. Rite Aid's revenue for the quarter was up .2% on a year-over-year basis. During the same period in the previous year, the company posted $0.01 EPS. View Rite Aid's Earnings History.

Rite Aid is scheduled to release their next quarterly earnings announcement on Thursday, April 9th 2020. View Earnings Estimates for Rite Aid.

Rite Aid updated its FY20 earnings guidance on Thursday, December, 19th. The company provided earnings per share guidance of $0.13-0.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.18. The company issued revenue guidance of $21.5-21.9 billion, compared to the consensus revenue estimate of $21.64 billion.

3 equities research analysts have issued 12 month target prices for Rite Aid's stock. Their forecasts range from $12.00 to $12.00. On average, they expect Rite Aid's stock price to reach $12.00 in the next year. This suggests that the stock has a possible downside of 25.2%. View Analyst Price Targets for Rite Aid.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 3 sell ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Rite Aid.

News articles about RAD stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Rite Aid earned a news sentiment score of 0.7 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Rite Aid.

Rite Aid saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 17,850,000 shares, an increase of 23.3% from the January 15th total of 14,480,000 shares. Based on an average trading volume of 6,500,000 shares, the short-interest ratio is currently 2.7 days. Currently, 33.9% of the company's stock are short sold. View Rite Aid's Current Options Chain.

Some companies that are related to Rite Aid include Covetrus (CVET), Petmed Express (PETS), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Mr. Cooper Group (COOP), Cleveland-Cliffs (CLF), Advanced Micro Devices (AMD), General Electric (GE), Lantronix (LTRX) and AK Steel (AKS).

Rite Aid's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (2.95%), Alberta Investment Management Corp (1.80%), Charles Schwab Investment Management Inc. (1.54%), Geode Capital Management LLC (1.33%), Creative Planning (1.01%) and Bank of New York Mellon Corp (0.56%). View Institutional Ownership Trends for Rite Aid.

RAD stock was sold by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp, Creative Planning, Ladenburg Thalmann Financial Services Inc., State Street Corp, Cubist Systematic Strategies LLC, Alliancebernstein L.P., UBS Asset Management Americas Inc. and Stifel Financial Corp. View Insider Buying and Selling for Rite Aid.

RAD stock was bought by a variety of institutional investors in the last quarter, including Charles Schwab Investment Management Inc., Geode Capital Management LLC, SG Americas Securities LLC, UBS Group AG, Bainco International Investors, Bank of New York Mellon Corp, Russell Investments Group Ltd. and Bank of America Corp DE. View Insider Buying and Selling for Rite Aid.

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of RAD stock can currently be purchased for approximately $16.04.

Rite Aid has a market capitalization of $879.31 million and generates $21.64 billion in revenue each year. Rite Aid employs 51,000 workers across the globe.View Additional Information About Rite Aid.

The official website for Rite Aid is http://www.riteaid.com/.

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]